RCDTF Stock - Recordati Industria Chimica e Farmaceutica S.p.A.
Unlock GoAI Insights for RCDTF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.34B | $2.08B | $1.85B | $1.58B | $1.45B |
| Gross Profit | $1.60B | $1.48B | $1.29B | $1.15B | $1.04B |
| Gross Margin | 68.3% | 71.1% | 69.4% | 72.9% | 71.9% |
| Operating Income | $638.86M | $558.01M | $437.33M | $490.19M | $469.02M |
| Net Income | $416.51M | $389.21M | $312.34M | $385.97M | $354.98M |
| Net Margin | 17.8% | 18.7% | 16.9% | 24.4% | 24.5% |
| EPS | $2.02 | $1.86 | $1.52 | $1.87 | $1.73 |
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.
Visit WebsiteEarnings History & Surprises
RCDTFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Feb 11, 2026 | — | — | — | — |
Q4 2025 | Nov 11, 2025 | — | $0.93 | — | — |
Q3 2025 | Jul 30, 2025 | $0.90 | $0.82 | -9.0% | ✗ MISS |
Q2 2025 | May 8, 2025 | — | $0.88 | — | — |
Q1 2025 | Feb 13, 2025 | — | $0.39 | — | — |
Q4 2024 | Nov 8, 2024 | $0.76 | $0.74 | -2.2% | ✗ MISS |
Q3 2024 | Jul 30, 2024 | $0.70 | $0.70 | +0.6% | ✓ BEAT |
Q2 2024 | May 9, 2024 | $0.74 | $0.85 | +14.1% | ✓ BEAT |
Q1 2024 | Feb 22, 2024 | $0.57 | $0.61 | +7.4% | ✓ BEAT |
Q3 2023 | Sep 30, 2023 | $0.57 | $0.39 | -32.0% | ✗ MISS |
Q3 2023 | Jul 4, 2023 | $0.53 | $0.54 | +2.7% | ✓ BEAT |
Q2 2023 | May 11, 2023 | $0.55 | $0.81 | +48.6% | ✓ BEAT |
Q4 2022 | Dec 31, 2022 | $0.52 | $0.37 | -30.3% | ✗ MISS |
Q4 2022 | Nov 8, 2022 | $0.53 | $0.63 | +18.6% | ✓ BEAT |
Q3 2022 | Jul 28, 2022 | $0.48 | $0.56 | +16.7% | ✓ BEAT |
Q2 2022 | May 10, 2022 | $0.52 | $0.48 | -8.0% | ✗ MISS |
Q1 2022 | Feb 28, 2022 | $0.56 | $0.47 | -15.7% | ✗ MISS |
Q4 2021 | Oct 28, 2021 | $0.56 | $0.50 | -10.4% | ✗ MISS |
Q3 2021 | Jul 29, 2021 | $0.57 | $0.66 | +16.7% | ✓ BEAT |
Latest News
Frequently Asked Questions about RCDTF
What is RCDTF's current stock price?
What is the analyst price target for RCDTF?
What sector is Recordati Industria Chimica e Farmaceutica S.p.A. in?
What is RCDTF's market cap?
Does RCDTF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to RCDTF for comparison